U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07264413) titled 'Bleeding Reduction in Grade II-III Haemorrhoids Through Embolization Treatment' on Nov. 20.
Brief Summary: BRIGHT is a Europe-wide study that will follow up to 250 adults with bleeding symptoms from haemmorhoids (Grade II-III categories). It aims to understand how well a minimally invasive procedure called haemorrhoid artery embolization (HAE) works in everyday clinical practice, which is a technique that blocks the blood vessels feeding the haemorrhoids. As this technique does not require major surgery, HAE offers several benefits such as less trauma, quicker recovery, and the use of only local anaesthesia.
Study Start Date: April,...